Rx abuse monitoring law
Executive Summary
President Bush signs the "National All Schedules Prescription Electronic Reporting Act" into law Aug. 11. The law, which passed the House July 27 and the Senate July 29, authorizes $60 mil. over fiscal years 2006-2010 for states to create or augment monitoring systems to track prescriptions of Schedule II-IV drugs across state lines (1"The Pink Sheet" Aug. 8, 2005, p. 27). The monitoring programs will require healthcare providers to report the dispensation of controlled substances within a week. Following a public comment period, the Secretary of HHS will establish minimum requirements, including certain privacy provisions, that states must meet in order to be eligible for grants under the law...
You may also be interested in...
Importation Limits In Future Trade Agreements Prevented Under Vitter Bill
Pharmaceutical importation prohibitions in future U.S. trade agreements would be forbidden under a bill co-sponsored by Sens. David Vitter (R-La.) and Debbie Stabenow (D-Mich.)
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.